Article
CAMK2D: A Novel Molecular Target for BAP1-Deficient Malignant Mesothelioma
2022-12-21
Abstract excerpt
<title>Abstract</title> <p>Malignant mesothelioma (MM) is a rare but aggressive malignancy. Although the molecular genetics of MM are known, including <italic>BRCA1-associated protein-1</italic> (<italic>BAP1</italic>) gene alterations, the prognosis of MM patients remains poor. Here we generated BAP1 knockout (<italic>BAP1</italic>-KO) human mesothelial cell clones to develop molecular-targeted therapeutics base...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8662d1f1-2a89-5936-8086-d3b26b87e95c
- DOI
- 10.21203/rs.3.rs-2323473/v1
